pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
BEAM-304
Phenylketonuria (PKU)
$BEAMBeam Therapeutics Inc.
0 catalysts
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)
ANI PHARMS
0 catalysts
BENZAMYCIN
BENZAMYCIN (ERYTHROMYCIN AND BENZOYL PEROXIDE)
VALEANT INTL
0 catalysts
BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%
BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% (BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%)
ALEMBIC
catalysts
← prev
page 62 of 231
next →
131
Pain89
Neurology1
0
BETADINE
BETADINE (POVIDONE-IODINE)
ALCON PHARMS LTD
0 catalysts
BETAINE ANHYDROUS
BETAINE ANHYDROUS (BETAINE ANHYDROUS)
$ETONEton Pharmaceuticals, Inc.
0 catalysts
Phase 1
BETR-001
Major Depressive Disorder
Better Life Pharmaceuticals Inc
0 catalysts
Preclinical
BF-844
Usher Syndrome
Case Western Reserve University
0 catalysts
Preclinical
BG-22
Solid Tumor
BioStar Pharmaceuticals Inc
0 catalysts
Preclinical
BG-319
Type 1 Diabetes (Juvenile Diabetes)
Bioorg3.14 LLC
0 catalysts
Preclinical
BGA-002
Small-Cell Lung Cancer
Biogenera SpA
0 catalysts
Phase 2
BGB-16673
Refractory Chronic Lymphocytic Leukemia (CLL)
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 1
BGBB-2033
Metastatic Hepatocellular Carcinoma (HCC)
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 2
BGC-101
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
BiogenCell Ltd
0 catalysts
Phase 1
BGC-515
Malignant Mesothelioma
BridGene Biosciences Inc
0 catalysts
Preclinical
BGI-9004
Malignant Mesothelioma
BridGene Biosciences Inc
0 catalysts
Phase 1
BGM-1812
Obesity
BrightGene Bio-Medical Technology Co Ltd
0 catalysts
Preclinical
BGT-DTDS
Neurology
Bloomsbury Genetic Therapies Ltd
0 catalysts
Preclinical
BGT-INAD
Neurodegenerative Diseases
Bloomsbury Genetic Therapies Ltd
0 catalysts
Preclinical
BGT-NPC
Niemann-Pick Disease Type C
Bloomsbury Genetic Therapies Ltd
0 catalysts
Preclinical
BGTF-027
Achromatopsia
Blue Gen Therapeutics Foundation
0 catalysts
Phase 1
BH-30236
Refractory Acute Myeloid Leukemia
BlossomHill Therapeutics Inc
0 catalysts
Phase 1
BH-3120
Solid Tumor
Hanmi Pharmaceuticals Co Ltd
0 catalysts
Phase 2
BHV-1510
Solid Tumor
$BHVNBiohaven Ltd.
0 catalysts
Phase 1
BHV-1530
Glioblastoma Multiforme (GBM)
$BHVNBiohaven Ltd.
0 catalysts
Phase 2
BI-1206
B-Cell Non-Hodgkin Lymphoma
BioInvent International AB
0 catalysts
Phase 2
BI-1808
Mycosis Fungoides
BioInvent International AB
0 catalysts
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
BI-836858
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Boehringer Ingelheim International GmbH
0 catalysts
BIDIL
BIDIL (HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE)
AZURITY
0 catalysts